obesity-995x60.png
FEATURED ARTICLES
Before AI Can Transform Clinical Trials, It Needs More Patient Data
King’s College London Professor Maddy Parsons says AI won't improve clinical trials — unless researchers begin collecting richer biological data, embracing diversity, and treating every clinical trial as learning opportunity.
-
![Start to finish-GettyImages-1410756550]( "i-Cubed Used End-To-End AI In A Proof-Of-Concept Trial. Here's What They Learned")
i-Cubed Used End-To-End AI In A Proof-Of-Concept Trial. Here's What They LearnedDiscover how well AI fared in document generation, patient engagement, data integration, and more in an end-to-end proof-of-concept study run by i-Cubed.
-
![Samir AI webinar_450x300]( "Why \"Steady Evolution\" Best Describes AI's Future")
Why "Steady Evolution" Best Describes AI's FutureI hosted a panel of clinical development veterans to separate AI hype from reality. Their message was clear: AI will change clinical trials, but success will depend less on the technology itself than on adoption, culture, and realistic expectations.
-
![Woman in depression-GettyImages-2175026346]( "Social Media Is Replete With Patient RWD, But How Can Researchers Best Use It?")
Social Media Is Replete With Patient RWD, But How Can Researchers Best Use It?Pistoia Alliance's Thierry Escudier and Aditya Tyagi discuss how social media listening is used in clinical research, how it supports established evidence-generation methods, and how it can become a credible, structured input for drug development.
SERVICES AND PRODUCTS
Rapidly reduced timelines and waste, and the prevention of costly product shortages
In a world that is constantly changing, the development of innovative personalised medicine is helping more of us to live healthier lives for longer. These leaps forward in drug development create new hope for patients.
Yet operating high-value, time-sensitive supply chains naturally brings additional challenge and risk. Challenge and risk that require a step change in production approach to effectively balance patient-centricity with commercial viability.
Almac Trial Coordinator™ is a unified eClinical orchestration solution designed to simplify the execution of complex clinical trials. It brings together core trial functions including Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), eConsent, visit and participant management, and clinical supply oversight within a single, cohesive ecosystem.
Rather than operating as a collection of disconnected point solutions, Almac Trial Coordinator™ is designed to coordinate workflows, data, and users across the clinical trial lifecycle. The result is a more efficient, transparent, and site-friendly way to run global studies.
Boost patient engagement. Simplify and reduce site workload. Enable real-time, local currency payments through the patient’s preferred method.
Trial Enablement Solutions
Digital health technologies have the potential to transform clinical trials, yet without careful planning and operational support, their implementation can create complexity, increase site burden, and jeopardize data quality.
Backed by over 20 years of experience across nearly 300 industry-sponsored trials, Ametris’ Digital Health Operations team delivers end-to-end trial enablement services to ensure seamless technology deployment, reduce site burden, and capture reliable, high-quality data.
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
Accelerate trials with a centralized digital workspace that replaces manual documents, boosts collaboration, supports remote access, ensures compliance, and provides real-time visibility.